Globavir
Global infectious disease company building world class therapeutics and diagnostics..
Launch date
Employees
Market cap
-
Enterprise valuation
AUD9—14m (Dealroom.co estimates Sep 2016.)
Los Altos California (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | <1m | <1m | <1m | <1m |
% growth | - | - | - | (25 %) |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $2.0m | Seed | |
$4.0m | Early VC | ||
N/A | $1.5m | Early VC | |
N/A | $4.0m | Series B | |
Total Funding | AUD17.8m |
Related Content
Recent News about Globavir
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.